Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-14 5:08 pm Purchase | 2021-07-09 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 12,714,404 20.400% | 12,714,404 (New Position) | Filing History |
| 2021-07-13 9:24 pm Unchanged | 2021-07-11 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 5,810,525 20.400% | 0 (Unchanged) | Filing History |
| 2021-06-21 8:17 pm Purchase | 2021-06-15 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 3,042,764 7.300% | 3,042,764 (New Position) | Filing History |
| 2021-04-29 5:17 pm Purchase | 2021-04-26 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.800% | 4,012,281 (New Position) | Filing History |
| 2021-04-22 5:03 pm Purchase | 2021-04-20 | 13D | Synlogic, Inc. SYBX | ORBIMED ADVISORS LLC | 246,444 7.400% | 111,111 (+82.10%) | Filing History |
| 2021-04-20 4:37 pm Purchase | 2021-04-13 | 13G | VectivBio Holding AG VECT | ORBIMED ADVISORS LLC | 4,830,004 13.800% | 4,830,004 (New Position) | Filing History |
| 2021-04-14 7:31 pm Purchase | 2021-03-30 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 161,407 6.560% | 161,407 (New Position) | Filing History |
| 2021-04-09 4:36 pm Purchase | 2021-04-06 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 72,873,494 84.000% | 70,422 (+0.10%) | Filing History |
| 2021-04-07 6:00 pm Purchase | 2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 13,679,055 27.800% | 13,679,055 (New Position) | Filing History |
| 2021-04-07 4:39 pm Sale | 2021-03-01 | 13D | Turning Point Therapeutics, Inc. TPTX | ORBIMED ADVISORS LLC | 1,743,950 3.600% | -283,600 (-13.99%) | Filing History |
| 2021-03-29 4:25 pm Unchanged | 2021-03-25 | 13D | Synlogic, Inc. SYBX | ORBIMED ADVISORS LLC | 135,333 5.100% | 0 (Unchanged) | Filing History |
| 2021-03-26 5:07 pm Unchanged | 2021-03-25 | 13D | Graybug Vision, Inc. GRAY | ORBIMED ADVISORS LLC | 297,382 19.800% | 0 (Unchanged) | Filing History |
| 2021-03-25 4:15 pm Purchase | 2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR | ORBIMED ADVISORS LLC | 61,200 7.600% | 19,567 (+47.00%) | Filing History |
| 2021-03-19 6:06 pm Sale | 2021-03-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,467,292 6.800% | -298,425 (-10.79%) | Filing History |
| 2021-03-03 6:50 pm Sale | 2021-03-01 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 6,186,307 12.600% | -1,220,000 (-16.47%) | Filing History |
| 2021-03-01 6:13 pm Purchase | 2021-02-17 | 13D | Decibel Therapeutics, Inc. DBTX | ORBIMED ADVISORS LLC | 4,061,774 16.700% | 4,061,774 (New Position) | Filing History |
| 2021-03-01 6:09 pm Unchanged | 2020-12-31 | 13G | KALA BIO, Inc. KALA | ORBIMED ADVISORS LLC | 188,568 8.410% | 0 (Unchanged) | Filing History |
| 2021-02-25 7:41 pm Sale | 2021-02-24 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 72,803,072 93.600% | -7,309 (-0.01%) | Filing History |
| 2021-02-22 6:31 pm Purchase | 2021-02-09 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 3,791,204 15.100% | 3,791,204 (New Position) | Filing History |
| 2021-02-22 3:47 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | ORBIMED ADVISORS LLC | 582,622 12.900% | 582,622 (New Position) | Filing History |